Dr Hannah West
Research Associate
- westh3@cardiff.ac.uk
- Adeilad Cochrane, Parc y Mynydd Bychan, Caerdydd, CF14 4YU
Cyhoeddiadau
2022
- Robinson, P. S. et al. 2022. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells. Nature Communications 13(1), article number: 3949. (10.1038/s41467-022-31341-0)
- Palles, C. et al. 2022. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. American Journal of Human Genetics 109(5), pp. 953-960. (10.1016/j.ajhg.2022.03.018)
2021
- Wills, C. et al. 2021. Genome-wide search for determinants of survival in 1,926 patients with advanced colorectal cancer with follow-up in over 22,000 patients. European Journal Of Cancer 159, pp. 247-258. (10.1016/j.ejca.2021.09.047)
- Watts, K. et al. 2021. Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer. International Journal of Cancer 149(9), pp. 1713-1722. (10.1002/ijc.33739)
- Prentzell, M. T. et al. 2021. G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling. Cell 184(3), pp. P655-674.E27. (10.1016/j.cell.2020.12.024)
- Thomas, L. E. et al. 2021. Duodenal adenomas and cancer in MUTYH-associated polyposis: an international cohort study. Gastroenterology 160(3), pp. 952-954. (10.1053/j.gastro.2020.10.038)
2018
- West, H. et al. 2018. Role for nucleotide excision repair gene variants in oxaliplatin-induced peripheral neuropathy. JCO Precision Oncology 2, pp. 1-18. (10.1200/PO.18.00090)